Cargando…

Influence of Age of Onset on Huntington’s Disease Phenotype

BACKGROUND: Older patients with Huntington’s disease (HD) are often thought to have a slower progressing disease course with less behavioral symptoms than younger patients. However, phenotypic differences based on age of onset have not been well characterized in a large HD population. This study wil...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kwa, Lauren, Larson, Danielle, Yeh, Chen, Bega, Danny
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Ubiquity Press 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7394225/ https://www.ncbi.nlm.nih.gov/pubmed/32775035 http://dx.doi.org/10.5334/tohm.536

Ejemplares similares

A Review of the Clinical Evidence for Complementary and Alternative Medicine in Huntington’s Disease
por: Yu, Margaret, et al.
Publicado: (2019)

Age-at-onset in Huntington disease
por: Orth, Michael, et al.
Publicado: (2011)

Does arterial hypertension influence the onset of Huntington's disease?
por: Valcárcel-Ocete, Leire, et al.
Publicado: (2018)

Understanding the Burdens Associated with Huntington’s Disease in Manifest Patients and Care Partners–Comparing to Parkinson’s Disease and the General Population
por: Exuzides, Alex, et al.
Publicado: (2022)

Glutathione S-Transferase Ω 1 variation does not influence age at onset of Huntington's disease
por: Arning, Larissa, et al.
Publicado: (2004)

Failure to confirm influence of Methyltetrahydrofolate reductase (MTHFR) polymorphisms on age at onset of Huntington disease
por: Hansen, Wiebke, et al.
Publicado: (2005)

Hypertension, antihypertensive drugs, and age at onset of Huntington’s disease
por: Zhu, Yahui, et al.
Publicado: (2023)

Formalizing a Residency Mentorship Program with a “Business of Medicine” Curriculum
por: Sampat, Ajay, et al.
Publicado: (2020)

Complementary & Alternative Management of Parkinson’s Disease: An Evidence-Based Review of Eastern Influenced Practices
por: Bega, Danny, et al.
Publicado: (2014)

Bioenergetics in fibroblasts of patients with Huntington disease are associated with age at onset
por: Gardiner, Sarah L., et al.
Publicado: (2018)

Overlap between age-at-onset and disease-progression determinants in Huntington disease
por: Aziz, N. Ahmad, et al.
Publicado: (2018)

PGC-1alpha as modifier of onset age in Huntington disease
por: Taherzadeh-Fard, Elahe, et al.
Publicado: (2009)

The Association between CAG Repeat Length and Age of Onset of Juvenile-Onset Huntington’s Disease
por: Schultz, Jordan L., et al.
Publicado: (2020)

No association between polymorphisms in the BDNF gene and age at onset in Huntington disease
por: Mai, Maren, et al.
Publicado: (2006)

Disease Onset in Huntington's Disease: When Is the Conversion?
por: Oosterloo, Mayke, et al.
Publicado: (2021)

Phenotypic Variability in Huntington's Disease
por: Chouksey, Anjali, et al.
Publicado: (2020)

Behavioral Deficits in Juvenile Onset Huntington’s Disease
por: Langbehn, Kathleen E., et al.
Publicado: (2020)

Brain structure in juvenile-onset Huntington disease
por: Tereshchenko, Alexander, et al.
Publicado: (2019)

The gene coding for PGC-1α modifies age at onset in Huntington's Disease
por: Weydt, Patrick, et al.
Publicado: (2009)

Meaning and purpose in Huntington’s disease: a longitudinal study of its impact on quality of life
por: Sokol, Leonard L., et al.
Publicado: (2021)

Special Issue: Juvenile Onset Huntington’s Disease
por: Nopoulos, Peg C.
Publicado: (2020)

Autonomic Changes in Juvenile-Onset Huntington’s Disease
por: Schultz, Jordan L., et al.
Publicado: (2020)

Phenotype onset in Huntington’s disease knock‐in mice is correlated with the incomplete splicing of the mutant huntingtin gene
por: Franich, Nicholas R., et al.
Publicado: (2019)

Huntington’s Disease Presenting as Adult-Onset Parkinsonism
por: Kwak, In Hee, et al.
Publicado: (2022)

Effect of Body Weight on Age at Onset in Huntington Disease: A Mendelian Randomization Study
por: van der Burg, Jorien M.M., et al.
Publicado: (2021)

Huntington’s disease age at motor onset is modified by the tandem hexamer repeat in TCERG1
por: Lobanov, Sergey V., et al.
Publicado: (2022)

Modulation at Age of Onset in Tunisian Huntington Disease Patients: Implication of New Modifier Genes
por: Hmida-Ben Brahim, Dorra, et al.
Publicado: (2014)

Advance Care Planning and Health-Related Quality of Life in Huntington Disease: Results from a Multicenter National Study
por: Sokol, Leonard L., et al.
Publicado: (2023)

Hypertension, Antihypertensive Use and the Delayed‐Onset of Huntington's Disease
por: Steventon, Jessica J., et al.
Publicado: (2020)

Candidate glutamatergic and dopaminergic pathway gene variants do not influence Huntington’s disease motor onset
por: Ramos, Eliana Marisa, et al.
Publicado: (2013)

Presynaptic Dopaminergic Dysfunction Was Overestimated in Huntington’s Disease Presenting as Young Age-Onset Parkinsonism
por: Kim, Taewon, et al.
Publicado: (2022)

Understanding HD Psychosis: An Analysis from the ENROLL-HD Database
por: Jaini, Ashwin, et al.
Publicado: (2020)

Genetic analysis of polymorphisms in the kalirin gene for association with age-at-onset in European Huntington disease patients
por: Tsai, Yu-Chun, et al.
Publicado: (2012)

Comorbid epilepsy in Finnish patients with adult-onset Huntington’s disease
por: Sipilä, Jussi O. T., et al.
Publicado: (2016)

Late-onset Huntington’s disease with 40–42 CAG expansion
por: Capiluppi, Elisa, et al.
Publicado: (2019)

Cerebrospinal fluid biomarkers for assessing Huntington disease onset and severity
por: Caron, Nicholas S, et al.
Publicado: (2022)

Juvenile‐Onset Huntington Disease Pathophysiology and Neurodevelopment: A Review
por: Bakels, Hannah S., et al.
Publicado: (2021)

Assessing the state of care for Huntington disease in the United States: Results from a survey of practices treating Huntington disease patients
por: Seeberger, Lauren, et al.
Publicado: (2022)

Association between Genetically Proxied Inhibition of HMG-CoA Reductase and Age at Onset of Huntington’s Disease
por: Zhu, Yahui, et al.
Publicado: (2022)

Delayed onset of the diurnal melatonin rise in patients with Huntington’s disease
por: Aziz, N. Ahmad, et al.
Publicado: (2009)

Cannot write session to /tmp/vufind_sessions/sess_onluobcrr2dfb120522lskq51n